Cefoxitin and Dextrose Injection and Nimodipine Oral Solution
Determining the interaction of Cefoxitin and Dextrose Injection and Nimodipine Oral Solution and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:Using cefOXitin together with niMODipine may increase the risk of kidney and/or nerve damage. Talk to your doctor if you have any questions or concerns. Your doctor may be able to prescribe alternatives that do not interact, or you may need a dose adjustment or more frequent monitoring to safely use both medications. You should seek medical attention if you experience signs and symptoms that may suggest kidney damage such as nausea, vomiting, loss of appetite, increased or decreased urination, sudden weight gain or weight loss, fluid retention, swelling, shortness of breath, muscle cramps, tiredness, weakness, dizziness, confusion, and irregular heart rhythm. Be sure to drink plenty of fluids if you develop diarrhea or vomiting during treatment with these medications, as dehydration can also harm the kidney. In addition, let your doctor know if you develop seizures; hearing problems; or numbness, burning or tingling in your hands and feet. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Professional:MONITOR: The concurrent or sequential use of two or more potentially nephrotoxic or neurotoxic drugs may increase the risk of toxicity. Patients who are elderly, debilitated, dehydrated, or who have preexisting renal dysfunction may have a higher risk of developing adverse reactions.
MANAGEMENT: Close clinical and laboratory monitoring of renal and neurologic function and drug serum concentrations (if clinically appropriate) is recommended.
- Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
- Cerner Multum, Inc. "Australian Product Information." O 0
Generic Name: cefoxitin
Brand name: Mefoxin
Synonyms: Cefoxitin, CefOXitin
Generic Name: nimodipine
Brand name: Nymalize, Nimotop
Synonyms: Nimodipine, NiMODipine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Cefoxitin and Dextrose Injection-Nimotop
- Cefoxitin and Dextrose Injection-Ninjacof
- Cefoxitin and Dextrose Injection-Ninjacof-XG
- Cefoxitin and Dextrose Injection-Ninlaro
- Cefoxitin and Dextrose Injection-Ninoprin
- Cefoxitin and Dextrose Injection-Nintedanib
- Nimodipine Oral Solution-Cefoxitin Intravenous
- Nimodipine Oral Solution-Cefoxitin Sodium
- Nimodipine Oral Solution-Cefpodoxime
- Nimodipine Oral Solution-Cefpodoxime Proxetil
- Nimodipine Oral Solution-Cefpodoxime Proxetil Suspension
- Nimodipine Oral Solution-Cefpodoxime Suspension